5F-EDMB-PINACA
| 5F-EDMB-PINACA | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
5F-EDMB-PINACA is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors, specifically the CB1 receptor and CB2 receptor. Synthetic cannabinoids like 5F-EDMB-PINACA are often found in products marketed as "herbal incense" or "potpourri" and are intended to be used as recreational drugs.
Chemical Structure[edit]
5F-EDMB-PINACA belongs to the indazole-3-carboxamide family. The chemical structure of 5F-EDMB-PINACA includes a fluorine atom, which is believed to increase its potency and duration of action. The full chemical name is N-(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl-1-(5-fluoropentyl)-1H-indazole-3-carboxamide.
Pharmacology[edit]
5F-EDMB-PINACA acts as a full agonist at the CB1 and CB2 receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including mood, memory, and pain sensation. The activation of these receptors by synthetic cannabinoids can lead to effects similar to those of tetrahydrocannabinol (THC), the active component of cannabis.
Legal Status[edit]
The legal status of 5F-EDMB-PINACA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. For example, in the United States, it is listed as a Schedule I substance under the Controlled Substances Act.
Health Risks[edit]
The use of synthetic cannabinoids like 5F-EDMB-PINACA has been associated with a range of adverse health effects. These can include tachycardia, hypertension, hallucinations, and seizures. In some cases, the use of these substances has been linked to severe outcomes such as acute kidney injury and death.
Related Pages[edit]
- Synthetic cannabinoid
- Cannabinoid receptor
- Endocannabinoid system
- Tetrahydrocannabinol
- Controlled Substances Act
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
